Impiricus

Impiricus, "The AI-Powered HCP Engagement Engine", is a pioneering company in the intersection of Health Care and Pharmaceutical industries. Founded in 2020 by a practicing physician and a senior pharmaceutical executive, it revolutionizes how life sciences companies support healthcare providers (HCPs).

This US-based startup boasts the largest opted-in network of HCPs, utilizing AI technology to seamlessly deliver evidence-based resources to HCPs, enhancing patient care through informed decision-making.

With guidance from a council of over 2000 trusted advisor HCPs, Impiricus is uniquely positioned to offer impactful and clinically meaningful interactions, reducing market entry costs while accelerating patient access to treatments.

In April 2023, Impiricus secured a $1.10M Early VC investment, reinforcing its strategic role in healthcare. This investment signals robust confidence in its transformative capabilities to ethically bridge pharma resources with clinicians.